688606 奧泰生物
按盤價 
48.610 -0.850 (-1.719%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.495 | 5.624 | 7.845 | 4.518 | 31.853 |
| 總資產報酬率 ROA (%) | 0.464 | 5.225 | 7.287 | 4.099 | 27.230 |
| 投入資產回報率 ROIC (%) | 0.488 | 5.528 | 7.682 | 4.363 | 29.997 | 邊際利潤分析 |
| 銷售毛利率 (%) | 52.916 | 50.948 | 55.718 | 48.782 | 59.933 |
| 營業利潤率 (%) | 11.078 | 27.814 | 39.871 | 28.035 | 41.133 |
| 息稅前利潤/營業總收入 (%) | 18.755 | 26.590 | 35.806 | 18.405 | 38.675 |
| 淨利潤/營業總收入 (%) | 9.792 | 24.308 | 34.955 | 23.888 | 34.984 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 79.005 | 77.145 | 84.738 | 82.361 | 118.590 |
| 價值變動淨收益/利潤總額(%) | 29.157 | 16.302 | 13.731 | 20.920 | 0.644 |
| 營業外收支淨額/利潤總額(%) | 0.534 | -0.252 | 0.631 | -7.163 | -0.896 | 償債能力分析 |
| 流動比率 (X) | 12.358 | 9.879 | 9.911 | 11.531 | 8.202 |
| 速動比率 (X) | 11.509 | 9.263 | 9.375 | 10.843 | 7.823 |
| 資產負債率 (%) | 5.519 | 6.979 | 7.229 | 6.912 | 11.165 |
| 帶息債務/全部投入資本 (%) | 1.136 | 1.317 | 1.775 | 2.049 | 4.131 |
| 股東權益/帶息債務 (%) | 8,680.126 | 7,474.424 | 5,527.391 | 4,768.372 | 2,313.053 |
| 股東權益/負債合計 (%) | 1,712.095 | 1,332.954 | 1,283.425 | 1,345.256 | 794.785 |
| 利息保障倍數 (X) | 2.462 | -23.045 | -8.290 | -2.373 | -18.477 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 71.487 | 56.340 | 46.776 | 57.130 | 18.425 |
| 存貨周轉天數 (天) | 176.913 | 136.597 | 163.664 | 178.004 | 76.563 |
| 備註： | 即時報價更新時間為 26/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
